Spyre Therapeutics, Inc. (SYRE)

SEC filing

Spyre Therapeutics, Inc.

SYRE · CIK 1636282

4 · Sep 3, 2026 · See Remarks King-Jones Heidy sold 28.40K shares at $87.35/share ($2.5M); exercised options for 56.80K shares

See Remarks King-Jones Heidy sold 28.40K shares at $87.35/share ($2.5M); exercised options for 56.80K shares

Could not load the primary document from EDGAR (SEC rate limit, timeout, or temporary upstream error). Refresh in a minute, or use View on SEC.gov.